BSEKABRA DRUGS LTD.LowNeutral
Announced Thu, 1 Oct, 2026 · 16:12 IST

AGM results: all 4 resolutions passed with over 99% majority

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.1%1-day move
₹18.95
prior close
₹19.46
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.8-0.1-5.0-2.7-4.1-1.6-1.3———————
Up moveDown movePending
AI summary

Aanjaay Industries (formerly Kabra Drugs) held its 37th AGM on 30 Sept 2026. All 4 resolutions passed with over 99% majority: (1) adoption of FY26 audited financials, (2) re-appointment of Mr. K N Anand as director, (3) appointment of Ms. Moonam Kapoor as Independent Director, and (4) appointment of Mrs. Twinkle Agarwal as Secretarial Auditor. One invalid vote of 6,58,500 shares noted for resolution 2 due to related party interest.

Likely market impact

Routine compliance filing. All resolutions passed easily, no material impact expected on stock price or shareholders.